Physician profile
Mark S Berman
NPI 1215080379
$1,227.92
in general payments reported to CMS, 2019-2025
8 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.03 · 2022: $123 · 2023: $312 · 2024: $559 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,068.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $280.69 | 2021-2024 | Mitraclip, Diamondback Coronary, Tacticath Ablation Catheter, Sensor Enabled |
| Edwards Lifesciences Corporation | $262.61 | 2022-2024 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $241.02 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $140.53 | 2023 | Impella |
| E.R. Squibb & Sons, L.L.C. | $134.99 | 2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.36 | 2023 | Lifevest |
| Stryker Corporation | $43.14 | 2025 | Flowtriever |
| Merck Sharp & Dohme LLC | $19.58 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.